Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...

New clinical trial results reveal gedatolisib significantly improves progression-free survival in advanced HR+/HER2– breast ...

A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or ...

Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Lantern Pharma has completed targeted enrolment for its multi-centre Phase II HARMONIC clinical trial of a disulfide small ...

Celcuity recently released positive results from its phase 3 VIKTORIA-1 trial, and is raising both debt and shares. Read what ...

In a randomized pilot study recently published in the Journal for ImmunoTherapy of Cancer, an international research team led ...

Corticosteroid use, particularly at high doses, decreases the effectiveness of ICI therapy in patients with non–small cell ...

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 ...

Survival Mission Android Free. Fight for survival in Jericho: Survival Mission, a horror shooter with roguelike mechanics, ...